UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): April 28, 2015
ALPHATEC HOLDINGS, INC.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
Delaware |
|
000-52024 |
|
20-2463898 |
(State or Other Jurisdiction
of Incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
|
|
5818 El Camino Real, Carlsbad, CA |
|
92008 |
(Address of Principal Executive Offices) |
|
(Zip Code) |
Registrants telephone number, including area code: (760) 431-9286
(Former Name or Former Address, if Changed Since Last Report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
(b) On April 28, 2015 the Board of Directors (the Board) of Alphatec Spine, Inc. and Alphatec Holdings, Inc. (the Company)
increased the size of the Board to 11 and appointed Donald A. Williams to the Board, effective April 28, 2015. Mr. Williams qualifies as independent under the definition promulgated by NASDAQ and therefore is eligible to be a member of the
both the Boards Audit Committee and its Nominating, Governance and Compensation Committee. The Company believes that Mr. Williams possesses specific attributes that qualify him to serve as a director of the Company, including the
perspective and experience he will bring based on his prior experience as a partner at two large public accounting firms, and his current experience as a member of the board of directors of other companies.
(c) Mr. Williams, age 56, is a 35-year veteran of the public accounting industry, retiring in 2014. Mr. Williams spent 18 years as an
Ernst & Young partner and the last seven years as a Partner with Grant Thornton. Mr. Williams career focused on private and public companies in the technology and life sciences sectors. During the last seven years at Grant
Thornton, he served as the national leader of Grant Thorntons life sciences practice and the managing partner of the San Diego Office. He was the lead partner for both Ernst & Young and Grant Thornton on multiple initial public
offerings; secondary offerings; private and public debt financings; as well as numerous mergers and acquisitions. From 2001 to 2014, Mr. Williams served on the board of directors and is past president and chairman of the San Diego Venture
Group. Mr. Williams also has serves as a director of Marina Biotech, Inc., Proove Biosciences, Inc. and is on the Board of Advisors of the Southern Illinois University School of Accountancy.
On May 1, 2015 the Company issued a press release announcing Mr. Williams appointment to the Board, a copy of which is
attached hereto as Exhibit 99.1 and incorporated herein by reference.
Item 9.01 |
Financial Statements and Exhibits. |
|
|
|
|
|
99.1 |
|
Press Release dated May 1, 2015 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
|
|
ALPHATEC HOLDINGS, INC.
(Registrant) |
|
|
|
|
Date: May 1, 2015 |
|
|
|
|
|
/s/ Ebun S. Garner, Esq. |
|
|
|
|
|
|
Ebun S. Garner, Esq. |
|
|
|
|
|
|
General Counsel and Senior Vice President |
Exhibit 99.1
FOR IMMEDIATE RELEASE
Alphatec Spine Announces Appointment of Donald A. Williams to its Board of Directors
CARLSBAD, CA, May 1, 2015 Alphatec Holdings, Inc. (Nasdaq: ATEC), the parent company of Alphatec Spine, Inc., a global provider of spinal fusion
technologies, announced today that its board of directors has appointed Donald A. Williams as a member of the board of directors, effectively immediately. Mr. Williams, was a partner at Ernst & Young for eighteen years and a Partner
with Grant Thornton, LLP for the last seven years. He has served as the lead partner on multiple initial public offerings, secondary offerings, private and public debt financings, as well as numerous mergers and acquisitions.
This appointment expands the Alphatec Spine board to 11 directors. Mr. Williams is qualified as an independent director under the definition established
by Nasdaq.
Don has a solid foundation of financial and business expertise, and we are delighted that he is joining Alphatecs board of
directors, said Jim Corbett, President and Chief Executive Officer. With over 30 years of audit experience across domestic and international businesses, Don will further strengthen our Boards breadth of talent and experience. His
contributions will be extremely valuable as we continue to execute on our strategic objectives.
I am very excited to be working with
Alphatecs experienced management team and accomplished Board, said Don Williams. I look forward to contributing to the Companys execution of both domestic and international growth and driving future profitability.
Mr. Williams, age 56, is a 35-year veteran of the public accounting industry, retiring in 2014. Mr. Williams spent 18 years as an Ernst &
Young partner and the last seven years as a Partner with Grant Thornton. Mr. Williams career focused on private and public companies in the technology and life sciences sectors. During the last seven years at Grant Thornton, he served as
the national leader of Grant Thorntons life sciences practice and the managing partner of the San Diego Office. He was the lead partner for both Ernst & Young and Grant Thornton on multiple initial public offerings; secondary
offerings; private and public debt financings; as well as numerous mergers and acquisitions. From 2001 to 2014, Mr. Williams served on the board of directors and is past president and chairman of the San Diego Venture Group. Mr. Williams
also has serves as a director of Marina Biotech, Inc., Proove Biosciences, Inc. and is on the Board of Advisors of the Southern Illinois University School of Accountancy.
Further information regarding the Companys appointment of Donald A. Williams to its board of directors is set forth in a Current Reports on Form 8-K
that was filed with the U.S. Securities and Exchange Commission (SEC) on May 1, 2015 and is available on both the SECs website at www.sec.gov and the Companys website at www.alphatecspine.com.
About Alphatec Spine
Alphatec Spine, Inc., a wholly
owned subsidiary of Alphatec Holdings, Inc., is a global medical device company that designs, develops, manufactures and markets spinal fusion technology products and
solutions for the treatment of spinal disorders associated with disease and degeneration, congenital deformities and trauma. The Companys mission is to improve lives by delivering
advancements in spinal fusion technologies. The Company and its affiliates market products in the U.S. and internationally via a direct sales force and independent distributors.
Additional information can be found at www.alphatecspine.com.
Forward Looking Statements
This press release may
contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that involve risks and uncertainty. Such statements are based on managements current expectations and are subject to a
number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Alphatec Spine cautions investors that there can be no assurance that actual results or business
conditions will not differ materially from those projected or suggested in such forward-looking statements as a result of various factors. Forward-looking statements include the Companys ability to achieve profitable growth; the Companys
ability to achieve both domestic and international growth and future profitability. The words believe, will, should, expect, intend, estimate and anticipate,
variations of such words and similar expressions identify forward-looking statements, but their absence does not mean that a statement is not a forward-looking statement. Please refer to the risks detailed from time to time in Alphatec
Spines SEC reports, including its Annual Report Form 10-K, as well as other filings on Form 10-Q and periodic filings on Form 8-K. Alphatec Spine disclaims any intention or obligation to update or revise any forward-looking statements, whether
as a result of new information, future events, or otherwise, unless required by law.
CONTACT: Investor/Media Contact:
Christine Zedelmayer
Investor Relations
Alphatec Spine, Inc.
(760) 494-6610
czedelmayer@alphatecspine.com
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Alphatec (NASDAQ:ATEC)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024